Assessment of Monkeypox (MPOX) Knowledge and Vaccination Intention among Health and Life Sciences Students in Algeria: A Cross-Sectional Study.

Mohamed Lounis, Ahmed Hamimes, Ali Dahmani
Author Information
  1. Mohamed Lounis: Department of Agro-Veterinary Sciences, Faculty of Natural and Life Sciences, University of Ziane Achour, BP 3117, Road of Moudjbara, Djelfa 17000, Algeria. ORCID
  2. Ahmed Hamimes: Laboratory of Biostatistics, Bioinformatics and Mathematical Methodology Applied to Health Sciences (BIOSTIM), Faculty of Medicine, University of Constantine 3, Constantine 25000, Algeria. ORCID
  3. Ali Dahmani: Institute of Veterinary Sciences, University of Blida 1, Blida 09000, Algeria.

Abstract

Monkeypox (MPOX) is a viral zoonotic disease affecting endemically the Central and Western regions of Africa. The ongoing outbreak in non-endemic countries has made this disease a global concern. While no cases have been reported in Algeria, it is important to raise awareness about the disease to prepare for a potential outbreak, especially in light of the cases reported in neighboring Middle East and North African (MENA) countries. This study aimed to evaluate the knowledge and attitude of Algerian Health and Life Sciences students toward MPOX and its vaccine through an anonymous online survey. A total of 196 students participated in this study. Students of medicine (64.3%), females (85.7%), and those under 20 years of age (55.1%) were the most represented. The results revealed a low level of knowledge represented by a score of only 42.8% for correct answers with multiple gaps in epidemiology, etiology, and clinical manifestations of MPOX. Students of veterinary sciences showed the highest levels of knowledge (OR: 6.71; CI95%: 1.23-36.77), while those aged between 20 and 30 years old (OR: 0.11; CI95%: 0.02-0.79) and those vaccinated against seasonal flu (OR: 0.42; CI95%: 0.21-0.85) were associated with low levels of knowledge. Regarding MPOX vaccination, the study found a moderate level of acceptance (48.5%) among the surveyed students with Natural and Life Sciences students and those having a high vaccine conspiracy belief score (VCBS) showing the lowest level of acceptance. These findings highlight the need for educational programs and intensified public awareness campaigns to improve knowledge about MPOX and emphasize the importance of vaccination in preventing outbreaks and overcoming vaccine reluctance.

Keywords

References

  1. Travel Med Infect Dis. 2022 Sep-Oct;49:102426 [PMID: 35963555]
  2. J Infect Public Health. 2022 Oct;15(10):1065-1071 [PMID: 36087548]
  3. Acta Trop. 2020 Jun;206:105450 [PMID: 32194068]
  4. Vaccines (Basel). 2022 Nov 26;10(12): [PMID: 36560432]
  5. Vaccines (Basel). 2023 Mar 08;11(3): [PMID: 36992194]
  6. BMJ. 2007 Oct 20;335(7624):806-8 [PMID: 17947786]
  7. Papillomavirus Res. 2016 Dec;2:167-172 [PMID: 29074176]
  8. Vaccines (Basel). 2022 Aug 19;10(8): [PMID: 36016243]
  9. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141 [PMID: 35148313]
  10. Vacunas. 2023 Apr-Jun;24(2):122-127 [PMID: 36852211]
  11. Pathogens. 2022 Oct 28;11(11): [PMID: 36364999]
  12. Pathogens. 2022 Aug 31;11(9): [PMID: 36145426]
  13. Vaccines (Basel). 2022 Sep 15;10(9): [PMID: 36146612]
  14. Medicina (Kaunas). 2022 Jul 11;58(7): [PMID: 35888642]
  15. Cureus. 2022 Aug 16;14(8):e28060 [PMID: 36127980]
  16. Int J Environ Res Public Health. 2021 Mar 01;18(5): [PMID: 33804558]
  17. Pathog Glob Health. 2020 Mar;114(2):68-75 [PMID: 32202967]
  18. EClinicalMedicine. 2022 Oct 31;54:101710 [PMID: 36345526]
  19. Healthcare (Basel). 2022 Sep 08;10(9): [PMID: 36141334]
  20. J Hosp Infect. 2022 Dec;130:144-145 [PMID: 36174773]
  21. J Pharm Policy Pract. 2023 Mar 7;16(1):39 [PMID: 36882801]
  22. Clin Epidemiol Glob Health. 2020 Dec;8(4):1259-1263 [PMID: 36245638]
  23. Vaccines (Basel). 2023 Jan 19;11(2): [PMID: 36851107]
  24. Rocz Panstw Zakl Hig. 2022;73(3):365-371 [PMID: 36169392]
  25. Trop Med Infect Dis. 2023 Jan 23;8(2): [PMID: 36828497]
  26. J Adv Nurs. 2023 Jul;79(7):2684-2694 [PMID: 36908101]
  27. Vaccines (Basel). 2022 Dec 31;11(1): [PMID: 36679942]
  28. Trop Med Infect Dis. 2022 Jul 14;7(7): [PMID: 35878146]
  29. Vaccines (Basel). 2022 Dec 21;11(1): [PMID: 36679864]
  30. Vaccine. 2020 Oct 7;38(43):6800-6806 [PMID: 32861468]
  31. Vaccines (Basel). 2022 Aug 28;10(9): [PMID: 36146486]
  32. PLoS One. 2022 Dec 1;17(12):e0278622 [PMID: 36454991]
  33. Vaccines (Basel). 2022 Oct 29;10(11): [PMID: 36366343]

Word Cloud

Created with Highcharts 10.0.0MPOXknowledgestudentsvaccine0diseasestudyLifeSciencesStudentslevelOR:CI95%:MonkeypoxoutbreakcountriescasesreportedAlgeriaawarenessHealth8520yearsrepresentedlowscore42levelsvaccinationacceptanceamongviralzoonoticaffectingendemicallyCentralWesternregionsAfricaongoingnon-endemicmadeglobalconcernimportantraisepreparepotentialespeciallylightneighboringMiddleEastNorthAfricanMENAaimedevaluateattitudeAlgeriantowardanonymousonlinesurveytotal196participatedmedicine643%females7%age551%resultsrevealed8%correctanswersmultiplegapsepidemiologyetiologyclinicalmanifestationsveterinarysciencesshowedhighest671123-3677aged30old1102-079vaccinatedseasonalflu21-0associatedRegardingfoundmoderate485%surveyedNaturalhighconspiracybeliefVCBSshowinglowestfindingshighlightneededucationalprogramsintensifiedpubliccampaignsimproveemphasizeimportancepreventingoutbreaksovercomingreluctanceAssessmentKnowledgeVaccinationIntentionAlgeria:Cross-SectionalStudyhealthlifesciencemonkeypoxhesitancy

Similar Articles

Cited By